Bulk Manufacturer of Controlled Substances Application: Boehringer Ingelheim Chemical, Inc., 32321 [2014-12956]
Download as PDF
<![CDATA[
32321
Federal Register / Vol. 79, No. 107 / Wednesday, June 4, 2014 / Notices
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[Docket No. DEA–392]
[Docket No. DEA–392]
[FR Doc. 2014–12956 Filed 6–3–14; 8:45 am]
Bulk Manufacturer of Controlled
Substances Application: Lin Zhi
International, Inc
Bulk Manufacturer of Controlled
Substances Application: Boehringer
Ingelheim Chemical, Inc.
BILLING CODE 4410–09–P
ACTION:
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before August 4, 2014.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR part 0,
subpart R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on March
27, 2014, Lin Zhi International, Inc., 670
Almanor Avenue, Sunnyvale, California
94085, applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
tkelley on DSK3SPTVN1PROD with NOTICES
II
II
II
II
II
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–12967 Filed 6–3–14; 8:45 am]
BILLING CODE 4410–09–P
VerDate Mar<15>2010
16:05 Jun 03, 2014
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before August 4, 2014.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR part 0,
subpart R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on May 2,
2014, Boehringer Ingelheim Chemical,
Inc., 2820 N. Normandy Drive,
Petersburg, Virginia 23805–9372,
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Jkt 232001
Controlled substance
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Methadone (9250) ........................
Methadone Intermediate (9254) ...
The company plans to manufacture
the listed controlled substances as bulk
reagents for use in drug abuse testing.
Drug Enforcement Administration
DATES:
Schedule
Cocaine (9041) .............................
Oxycodone (9143) ........................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Morphine (9300) ...........................
Notice of application.
Schedule
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for sale to its customers for formulation
into finished pharmaceuticals. In
reference to Methadone Intermediate
(9254), the company plans to produce
Methadone HCL active pharmaceutical
ingredients (APIs) for sale to its
customers.
PO 00000
Frm 00109
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Apertus
Pharmaceuticals
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before August 4, 2014.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR part 0,
subpart R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on March
20, 2014, Apertus Pharmaceuticals, 331
Concort Drive, St. Louis, Missouri
63011, applied to be registered as a bulk
manufacturer of the following basic
classes of narcotic or nonnarcotic
controlled substances:
DATES:
Controlled substance
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
Schedule
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
E:\FR\FM\04JNN1.SGM
04JNN1
]]>Agencies
[Federal Register Volume 79, Number 107 (Wednesday, June 4, 2014)]
[Notices]
[Page 32321]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-12956]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application:
Boehringer Ingelheim Chemical, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before August 4, 2014.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, and dispensers of controlled substances
(other than final orders in connection with suspension, denial, or
revocation of registration) has been redelegated to the Deputy
Assistant Administrator of the DEA Office of Diversion Control
(``Deputy Assistant Administrator'') pursuant to sec. 7(g) of 28 CFR
part 0, subpart R, App.
In accordance with 21 CFR 1301.33(a), this is notice that on May 2,
2014, Boehringer Ingelheim Chemical, Inc., 2820 N. Normandy Drive,
Petersburg, Virginia 23805-9372, applied to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Methadone (9250)........................... II
Methadone Intermediate (9254).............. II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for sale to its customers for formulation into finished
pharmaceuticals. In reference to Methadone Intermediate (9254), the
company plans to produce Methadone HCL active pharmaceutical
ingredients (APIs) for sale to its customers.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-12956 Filed 6-3-14; 8:45 am]
BILLING CODE 4410-09-P
